Literature DB >> 20113977

Role of acute infection in triggering acute coronary syndromes.

Vicente F Corrales-Medina1, Mohammad Madjid, Daniel M Musher.   

Abstract

Acute coronary syndromes are a leading cause of morbidity and mortality worldwide. The mechanisms underlying the triggering of these events are diverse and include increased coronary and systemic inflammatory activity, dominant prothrombotic conditions, increased biomechanical stress on coronary arteries, variations in the coronary arterial tone, disturbed haemodynamic homoeostasis, and altered myocardial metabolic balance. There is experimental evidence that acute infections can promote the development of acute coronary syndromes, and clinical data strongly support a role for acute infections in triggering these events. In our Review, we summarise the pathogenesis of coronary artery disease and present the evidence linking acute infections with the development of acute coronary syndromes. Greater awareness of this association is likely to encourage research into ways of protecting patients who are at high risk. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20113977     DOI: 10.1016/S1473-3099(09)70331-7

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  115 in total

1.  Seasonal Influenza Infections and Cardiovascular Disease Mortality.

Authors:  Jennifer L Nguyen; Wan Yang; Kazuhiko Ito; Thomas D Matte; Jeffrey Shaman; Patrick L Kinney
Journal:  JAMA Cardiol       Date:  2016-06-01       Impact factor: 14.676

Review 2.  Role of serum amyloid A in atherosclerosis.

Authors:  Preetha Shridas; Lisa R Tannock
Journal:  Curr Opin Lipidol       Date:  2019-08       Impact factor: 4.776

3.  Hospitalized Infection as a Trigger for Acute Ischemic Stroke: The Atherosclerosis Risk in Communities Study.

Authors:  Logan T Cowan; Alvaro Alonso; James S Pankow; Aaron R Folsom; Wayne D Rosamond; Rebecca F Gottesman; Kamakshi Lakshminarayan
Journal:  Stroke       Date:  2016-05-10       Impact factor: 7.914

4.  Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population.

Authors:  David T Gilbertson; Kenneth J Rothman; Glenn M Chertow; Brian D Bradbury; M Alan Brookhart; Jiannong Liu; Wolfgang C Winkelmayer; Til Stürmer; Keri L Monda; Charles A Herzog; Akhtar Ashfaq; Allan J Collins; James B Wetmore
Journal:  J Am Soc Nephrol       Date:  2019-01-24       Impact factor: 10.121

Review 5.  Seasonal variations in cardiovascular disease.

Authors:  Simon Stewart; Ashley K Keates; Adele Redfern; John J V McMurray
Journal:  Nat Rev Cardiol       Date:  2017-05-18       Impact factor: 32.419

6.  High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial.

Authors:  Orly Vardeny; Jacob A Udell; Jacob Joseph; Michael E Farkouh; Adrian F Hernandez; Alison J McGeer; H Keipp Talbot; Deepak L Bhatt; Christopher P Cannon; Shaun G Goodman; Inder Anand; David L DeMets; Jon Temte; Janet Wittes; Kristin Nichol; Clyde W Yancy; J Michael Gaziano; Lawton S Cooper; KyungMann Kim; Scott D Solomon
Journal:  Am Heart J       Date:  2018-05-23       Impact factor: 4.749

Review 7.  Long-term prognosis in community-acquired pneumonia.

Authors:  Marcos I Restrepo; Paola Faverio; Antonio Anzueto
Journal:  Curr Opin Infect Dis       Date:  2013-04       Impact factor: 4.915

8.  Longitudinal Study of the Effects of Bacteremia and Sepsis on 5-year Risk of Cardiovascular Events.

Authors:  S Reza Jafarzadeh; Benjamin S Thomas; David K Warren; Jeff Gill; Victoria J Fraser
Journal:  Clin Infect Dis       Date:  2016-05-18       Impact factor: 9.079

9.  Pneumolysin activates neutrophil extracellular trap formation.

Authors:  J G Nel; A J Theron; C Durandt; G R Tintinger; R Pool; T J Mitchell; C Feldman; R Anderson
Journal:  Clin Exp Immunol       Date:  2016-03-02       Impact factor: 4.330

10.  Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia.

Authors:  Oriol Sibila; Eric M Mortensen; Antonio Anzueto; Elena Laserna; Marcos I Restrepo
Journal:  Eur Respir J       Date:  2013-04-18       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.